Arena Pharmaceuticals Inc. obtained a $100 million credit facility from its largest shareholder, Deerfield Management, providing much-needed funding to propel obesity drug lorcaserin through FDA review and add muscle to ongoing partnership discussions. (BioWorld Today) Read More
